Body mass index vs. waist‐to‐height‐ratio in patients with lipohyperplasia dolorosa (vulgo lipedema)
Erich Brenner, Isabel Forner‐Cordero, Gabriele Faerber, Stefan Rapprich, Manuel Cornely- Dermatology
Summary
Background
Lipedema, also known as lipohyperplasia dolorosa (LiDo), is a painful condition affecting women, causing a disproportionate accumulation of subcutaneous adipose tissue in the extremities. It carries a lower risk of diabetes and cardio‐metabolic dysfunctions compared to obesity, but coincident obesity can complicate diagnosis and treatment.
Patients and Methods
This retrospective study included 607 female LiDo patients, ≥ 18 years, stage 1–3, from Germany, the UK, and Spain. Data were collected as part of the standard initial assessment for LiDo patients.
Results
Based on waist‐to‐height‐ratio (WHtR), 15.2% of patients were underweight, 45.5% normal weight, 22.1% overweight and 17.3% obese. There was a significant association between WHtR category and age group. Body mass index (BMI) is often overestimated, leading to misdiagnosis of obesity.
Conclusions
The use of BMI also affects the recent decision of the German Federal Joint Committee on the reimbursement of liposuction costs by health insurance funds. Patients with BMI of more than 40 kg/m2 are excluded from cost coverage, and those with BMI between 35 kg/m2 and 40 kg/m2 must first receive conservative obesity therapy. In conclusion, the sole use of BMI in lipedema is unreliable and, in contrast to WHtR, leads to inaccurate diagnoses overestimating overweight and obesity.